Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers
Huiling Xu, Max Yan, Jennifer Patra, Rachael Natrajan, Yuqian Yan, Sigrid Swagemakers, Jonathan M Tomaszewski, Sandra Verschoor, Ewan KA Millar, Peter van der Spek, Jorge S Reis-Filho, Robert G Ramsay, Sandra A O'Toole, Catriona M McNeil, Robert L Sutherland, Michael J Mckay, Stephen B Fox
Breast Cancer Research | BIOMED CENTRAL LTD | Published : 2011
Awarded by Victorian Cancer Biobank, Cancer Council Victoria
Awarded by National Health and Medical Research Council
This study was supported in part by the Victorian Breast Cancer Research Consortium, the Victorian Cancer Biobank, Cancer Council Victoria (Grant 091224 to HX and MJM), Cancer Institute of New South Wales, the Australian Cancer Research Foundation, the Petre Foundation, the National Health and Medical Research Council (Project grant 400207 to HX; Project Grants: 535903 and 535947 to EAKM and RLS) and the RT Hall Trust, Australia. SS is supported by grants from the Netherlands Genomics Initiative (NGI)/NWO.